L

LatchBio

Cloud-based data platform for biotech R&D

AI Biologist - Rare and Progressive Disease

Quantitative Biology & BiostatisticsUpdated on Nov 8
Full-timeSan Francisco, CA, USA$140k - $180k /yr

About the Job

Requirements

  • An advanced degree (MS, MD, PhD, or PharmD) in biology, genetics, physiology, computational biology, or a related biomedical field is required.
  • At least 3 years of hands-on research experience in relevant domains, with impact demonstrated through publications or industry experience, is required.
  • Proficiency in Python and/or R for biological data analysis and visualization, or expert-level experience in experimental or methods design, is required.
  • Deep scientific or clinical expertise in at least one relevant disease area, including rare genetic, autoimmune, infectious, or idiopathic diseases; neurodegeneration; or chronic progressive conditions such as COPD or MASH, is required.
  • Expertise in designing and troubleshooting relevant wet- or dry-lab experiments, or expertise in clinical diagnosis, treatment, and research, is required.

Responsibilities

  • Contribute to the technical approach for evaluating how AI agents can help diagnose, treat, conduct research, and perform target discovery in rare and progressive disease.
  • Work with scientists, physician-scientists, software engineers, and computational biologists to build ground-truth benchmark datasets drawn from studies, personal experience, and novel work.
  • Develop rigorous tests of whether AI agents can perform critical analytical and interpretative steps carried out by expert scientists.
  • Help define strategy across multiple benchmarks.

Desired Qualifications

  • Strong existing opinions on where agents and large language models fail in science or clinical practice.
  • Experience using agentic coding systems.

About the Company

LatchBio

Cloud-based data platform for biotech R&D

Latch.bio provides a cloud-based data platform for biotech companies to manage and analyze their data. It stores unlimited raw data, organizes and transforms it, and offers analysis tools, all in one place. The platform also includes workflow orchestration, so teams can set up analyses that automatically run across many computing cores and scale as needed, while the interface makes it easy to view analysis results and make quick decisions. A key feature is a customizable data platform that eliminates the need for separate infrastructure setup and supports strong security for large-scale data processing. Compared with competitors, Latch.bio positions itself as a single, cost-efficient solution that replaces multiple tools and optimizes cloud usage to reduce expenses. Its goal is to help biotech companies move projects forward faster by making data analysis cheaper, simpler, and more accessible.

Company size
51-200
Company stage
Series B
Total funding
$163M
Headquarters
San Francisco, CA
Founded
2021

Recently Posted Jobs

Explore more opportunities at LatchBio

See more jobs